The Senate Finance Committee released a draft bill that would create a new program within Medicare aimed at incentivizing hospitals, group purchasing organizations (GPOs) and other drug supply chain stakeholders to help create stable pricing for generic drug manufacturers by rewarding quality, reliability and long-term sustainable contracts. The proposed draft released Friday (May 3) would also make changes to the Medicaid Drug Rebate Program (MDRP) to address generic drug that are dispensed at retail pharmacies by adjusting the generic drug...